Coartem(®): a decade of patient-centric malaria management.

  title={Coartem(®): a decade of patient-centric malaria management.},
  author={Kamal Hamed and Heiner Grueninger},
  journal={Expert review of anti-infective therapy},
  volume={10 6},
The adoption of artemisinin-based combination therapy, together with other malaria control strategies, has played a significant role in reducing the burden of malaria in many endemic countries. The artemisinin-based combination therapy artemether-lumefantrine (AL; Coartem(®), Novartis Pharma AG, Basel, Switzerland) has demonstrated consistently high efficacy and safety for over a decade. Currently deployed as a first- or second-line treatment in most sub-Saharan African countries, its extensive… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.
4 Citations
43 References
Similar Papers


Publications referenced by this paper.
Showing 1-10 of 43 references

Similar Papers

Loading similar papers…